SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zebra 365 who wrote (19375)3/8/1999 11:27:00 PM
From: Mkilloran  Read Replies (2) of 23519
 
Zebra....this should attract some intrest for a USA sales partner for MUSE, ALIBRA , Gene Therapy and now the patern for women...

The spotlight is back on VVUS......it's been in the dark too long.

Germany was the last milestone country $2million payment..looking for
Spain and France this qtr for an additional $4 million and Italy for next qtr for another $2 million from ASTRA.....

China $2 million from Janssen could hit 2nd qtr

How much can Vivus get for Japan and the USA????
Alibra moving along in Phase III trials and the future looks brighter for Gene Therapy with the work that DR G Christ is doing at Albert Einstein Medical center...Happy RATS

Now were hearing that the female Cats are Happy as well....

Look for Vivus to be back in double digits fast and the 5+ million shorts are on the run.......

GO VIVUS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext